Results

eNauka >  Results >  Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial
Title: Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial
Authors Szarek, Michael; ...; Dilić, Mirza; ...; Ristić, Arsen D.  ; ...; Miličić, Davor; ...; Simić, Dragan V.  ; Ivanović, Nikola;
Issue Date: 2019
Publication: Journal of the American College of Cardiology
ISSN: 0735-1097 e1558-3597 Journal of the American College of Cardiology
Publisher: Elsevier Biomedical, New York
Type: Article
Collation: vol. 73 br. 4 str. 387-396
DOI: 10.1016/j.jacc.2018.10.039
WoS-ID: 000456818200001
Scopus-ID: 2-s2.0-85060287356
URI: https://enauka.gov.rs/handle/123456789/821567
URL: https://www.sciencedirect.com/science/article/pii/S0735109718389617?via%3Dihub
Project: Sanofi-Aventis
Regeneron Pharmaceuticals, Inc.
Fondation Assistance Publique-Hopitaux de Paris
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21aM21a

129
SCOPUSTM
107
OpenCitations
116
WEB OF SCIENCETM
Altmetric
Dimensions

Report a mistake

This message will be sent to your editor

Description field cannot be empty

Find the DOI

Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.